| A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis (NCT03062618) | PRCL Research Inc. | 2017-02-20 |
| Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects (NCT03041792) | Pfizer | 2017-02-20 |
| Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease (NCT03068481) | Kissei Pharmaceutical Co., Ltd. | 2017-02-20 |
| Study of DC-CTL Combined With CIK for Advanced Solid Tumor (NCT03047525) | Xiaoyi Huang | 2017-02-20 |
| A Comparison of VR647 and Conventionally Nebulized Budesonide in Healthy Volunteers and Adult Asthma Subjects (NCT04032834) | Vectura Limited | 2017-02-20 |
| Study to Assess the Relative Bioavailability of Fixed-Dose Combination (FDC) Tablet (Simeprevir, Odalasvir and AL-335) Compared With Single Agents Administered Together, and to Assess the Effect of Multiple-Dose Lansoprazole or Omeprazole on Single-Dose Pharmacokinetics of SMV, ODV, and AL-335 (FDC) (NCT03059303) | Janssen Research & Development, LLC | 2017-02-20 |
| Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma (NCT03042182) | Immunitor LLC | 2017-02-20 |
| Use of Stem Cells in Diabetes Mellitus Type 1 (NCT02940418) | Sophia Al-Adwan | 2017-02-19 |
| A Phase 1, Study to Evaluate HTI-2088 Tablet (NCT03203811) | Hengrui Therapeutics, Inc. | 2017-02-17 |
| A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus (NCT02910518) | Sanofi | 2017-02-17 |
| First-in-Human Dose Escalation Study of M201-A in Healthy Japanese Subjects (NCT03055403) | Yuji KUMAGAI | 2017-02-17 |
| The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930 (NCT03034486) | Chong Kun Dang Pharmaceutical | 2017-02-17 |
| Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease (NCT03056729) | Biogen | 2017-02-17 |
| A Study Of Pembrolizumab In Combination With Trastuzumab-DM1 (NCT03032107) | Dana-Farber Cancer Institute | 2017-02-17 |
| The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout (NCT03131583) | Jiangsu HengRui Medicine Co., Ltd. | 2017-02-17 |
| A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions (NCT03136237) | BioCryst Pharmaceuticals | 2017-02-17 |
| Fecal Microbiota Transplantation as a Strategy to Eradicate Resistant Organisms (NCT02543866) | Seattle Children's Hospital | 2017-02-17 |
| Islet Transplantation Using PKX-001 (NCT03073577) | University of Alberta | 2017-02-17 |
| The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy (NCT02815540) | Gillette Children's Specialty Healthcare | 2017-02-16 |
| First in Human Single Ascending Dose Study of MOR107 (NCT03067363) | Alan Richardson | 2017-02-16 |
| Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor (NCT03069469) | Deciphera Pharmaceuticals, LLC | 2017-02-16 |
| Autologous Platelet Lysate in Corneal Epithelial Defects (NCT02979912) | Hanan Jafar | 2017-02-16 |
| Safety and Tolerability of GX-I7 in HPV-infected Female Volunteers (NCT03144934) | Genexine, Inc. | 2017-02-16 |
| Study Evaluating Safety and Efficacy of INCB050465 Combined With Bendamustine and Obinutuzumab in Relapsed or Refractory Follicular Lymphoma (CITADEL-102) (NCT03039114) | Incyte Corporation | 2017-02-15 |
| BCMA Chimeric Antigen Receptor Expressing T Cells in Multiple Myeloma (NCT03093168) | The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine | 2017-02-15 |
| A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML) (NCT03040401) | Vastra Gotaland Region | 2017-02-15 |
| Drug-drug Interaction (DDI) Study to Assess ODM-201 as a Victim of CYP3A4 Inhibition or Induction (NCT03048110) | Bayer | 2017-02-15 |
| BI 443651 Multiple Rising Dose in Healthy Volunteers Followed by a Cross-over in CF Subjects (NCT02976519) | Boehringer Ingelheim | 2017-02-15 |
| The FIGHT-RP1 Study (NCT03063021) | Johns Hopkins University | 2017-02-15 |
| Safety and Immunogenicity of a First-in-Human Mosquito Saliva Peptide Vaccine (NCT03055000) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-02-15 |
| Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids (NCT03023891) | Vanderbilt University Medical Center | 2017-02-15 |
| Study of LM11A-31-BHS in Mild-moderate AD Patients (NCT03069014) | PharmatrophiX Inc. | 2017-02-15 |
| T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation (NCT03180216) | Children's National Research Institute | 2017-02-15 |
| Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015) (NCT02927210) | Kimberly Myer | 2017-02-15 |
| Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC (NCT03046992) | Yuhan Corporation | 2017-02-15 |
| A Pharmacokinetic Study of MABp1 in Healthy Volunteers (NCT03047317) | Janssen Research & Development, LLC | 2017-02-15 |
| Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients (NCT02877550) | Swiss Cancer Institute | 2017-02-15 |
| PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies (NCT03030001) | Ningbo Cancer Hospital | 2017-02-15 |
| Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Lidocaine Patch 5% and Lidocaine Medicated Plaster 5% in Healthy, Adult, Human Subjects (NCT04320173) | Scilex Pharmaceuticals, Inc. | 2017-02-14 |
| A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-63623872/Oseltamivir Fixed-dose Combination Tablet and Single Agent Concept Formulations of JNJ-63623872 Compared to Their Respective Reference Formulation in Healthy Adult Participants (NCT03023852) | Janssen-Cilag International NV | 2017-02-14 |
| Spinal Cord Injury Neuroprotection With Glyburide (NCT02524379) | Ohio State University | 2017-02-14 |
| Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects (NCT03458208) | Geropharm | 2017-02-14 |
| Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma (NCT03015896) | David Bond, MD | 2017-02-14 |
| RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas (NCT02871843) | EpicentRx, Inc. | 2017-02-14 |
| Study to Evaluate the Safety and Tolerability of a Once Daily Dose of 50 mg E2609 in Healthy Japanese Subjects (NCT03055962) | Eisai Co., Ltd. | 2017-02-14 |
| A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis (NCT03004846) | GlaxoSmithKline | 2017-02-13 |
| BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma (NCT02872259) | Haukeland University Hospital | 2017-02-13 |
| First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845 (NCT03054402) | Bayer | 2017-02-13 |
| Study Comparing TPI-120 and Neulasta Administered Through Subcutaneous Route in Healthy Adult Subjects (NCT03206229) | Adello Biologics, LLC | 2017-02-13 |
| A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma (NCT03006926) | Eisai Co., Ltd. | 2017-02-13 |
| Intrathecal Tetanus Immunoglobulin to Treat Tetanus (NCT02999815) | Oxford University Clinical Research Unit, Vietnam | 2017-02-13 |
| Ascending Doses of Autologous FDP vs FFP (NCT02930226) | U.S. Army Medical Research and Development Command | 2017-02-13 |
| Trazodone Dose Tolerance and APAP Adherence (NCT02945644) | Louis Stokes VA Medical Center | 2017-02-13 |
| Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer (NCT03043599) | H. Lee Moffitt Cancer Center and Research Institute | 2017-02-13 |
| Effects of 2% IDL Lotion on Skin Hydration and Transepidermal Water Loss in Females With Dry Skin (NCT04253704) | Shyla Cantor | 2017-02-13 |
| A Study of APG-1252 in Patients With SCLC or Other Solid Tumors (NCT03080311) | Ascentage Pharma Group Inc. | 2017-02-12 |
| Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma (NCT02928029) | Bayer | 2017-02-10 |
| A Study Evaluating Tolerability, Pharmacokinetics, and Preliminary Efficacy of HC-1119 in Patients. (NCT03774056) | Hinova Pharmaceuticals Inc. | 2017-02-10 |
| Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor (NCT02678533) | Assistance Publique - Hôpitaux de Paris | 2017-02-10 |
| Harnessing the Power of Technology: MOMBA for Postpartum Smoking (NCT02237898) | Yale University | 2017-02-10 |
| Pilot Study Of Anti-Programmed Death Ligand-1 (Anti-PD-L1, Atezolizumab) In Asymptomatic Myeloma (NCT02784483) | Yale University | 2017-02-10 |
| A Study of MIL62 in Treatment of CD20 Positive B-cell Lymphomas (NCT04103905) | Beijing Mabworks Biotech Co., Ltd. | 2017-02-10 |
| Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer (NCT02808143) | Northwestern University | 2017-02-10 |
| A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation (NCT03042299) | Takeda | 2017-02-10 |
| Safety and Efficacy of Autologous Umbilical Cord Blood Mononuclear Cells Transfusion in Neonates (NCT03053076) | Guangdong Women and Children Hospital | 2017-02-10 |
| EYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) Infection (NCT03320616) | Enyo Pharma | 2017-02-10 |
| Differential Responses to Drugs and Sweet Tastes (NCT03810703) | University of Chicago | 2017-02-09 |
| Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes (NCT02987738) | Kinderkrankenhaus auf der Bult | 2017-02-09 |
| Scintigraphy Study to Compare the Antireflux Activity of the Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects (NCT03065816) | Sanofi | 2017-02-09 |
| Molecular Fluorescence Endoscopy of (Pre)Malignant Esophageal Lesions (NCT03205501) | University Medical Center Groningen | 2017-02-09 |
| Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC) (NCT02950259) | Providence Health & Services | 2017-02-09 |
| A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 (NCT03058289) | Intensity Therapeutics, Inc. | 2017-02-09 |
| Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers (NCT03554304) | Wockhardt | 2017-02-09 |
| Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer (NCT02995330) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-02-09 |
| Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma (NCT02698111) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2017-02-08 |
| Safety and Pharmacokinetic Study of OMT-28 in Healthy Subjects (NCT03078738) | Omeicos Therapeutics GmbH | 2017-02-08 |
| Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response (NCT02290041) | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 2017-02-08 |
| Dose Escalation Study of TAB08 in Patients With Advanced Solid Neoplasms (NCT03006029) | Theramab LLC | 2017-02-08 |
| Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation (NCT03002519) | Pluristem Ltd. | 2017-02-08 |
| A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological Malignancies (NCT02937675) | Effector Therapeutics | 2017-02-08 |
| Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer (NCT02948426) | National Cancer Institute (NCI) | 2017-02-08 |
| Efficacy of Decitabine in Clearance of MRD (NCT03021395) | Institute of Hematology & Blood Diseases Hospital, China | 2017-02-08 |
| Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia (NCT03031249) | Institute of Hematology & Blood Diseases Hospital, China | 2017-02-08 |
| Efficacy and Safety of Chidamide in CBF Leukemia (NCT03031262) | Institute of Hematology & Blood Diseases Hospital, China | 2017-02-08 |
| Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjects (NCT03071081) | Topivert Pharma Ltd | 2017-02-08 |
| FLYSYN in MRD Positive AML (NCT02789254) | Synimmune GmbH | 2017-02-07 |
| Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLL (NCT02973399) | Esanex Inc. | 2017-02-07 |
| Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas (NCT03036904) | Weill Medical College of Cornell University | 2017-02-06 |
| Body Compartment PK for New HIV Pre-exposure Prophylaxis Modalities (NCT02985996) | Emory University | 2017-02-06 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B (NCT03038113) | Hoffmann-La Roche | 2017-02-06 |
| A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations (NCT03010059) | Janssen Research & Development, LLC | 2017-02-06 |
| Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer (NCT02901301) | Yonsei University | 2017-02-06 |
| Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients (NCT03055286) | JW Pharmaceutical | 2017-02-06 |
| Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers (NCT03071679) | Maruho Co., Ltd. | 2017-02-06 |
| Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers (NCT02991261) | Sun Pharma Advanced Research Company Limited | 2017-02-06 |
| Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2292767 in Healthy Participants Who Smoke Cigarettes (NCT03045887) | GlaxoSmithKline | 2017-02-06 |
| Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion) (NCT03091933) | Ciusss de L'Est de l'Île de Montréal | 2017-02-06 |
| Evaluation of Metabolic Markers for the Prediction of DDI of Various CYP3A Substrates and Inhibitors (NCT02975037) | Seoul National University Hospital | 2017-02-06 |
| TRK-700 Drug-Drug Interaction Study With Digoxin and Midazolam (NCT03043248) | Toray Industries, Inc | 2017-02-06 |
| Clinical Study of Atezolizumab (Anti-PD-L1) and Sipuleucel-T in Patients With Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer (NCT03024216) | University of Hawaii | 2017-02-06 |